Residual Kidney Function Modifies the Effect of Cinacalcet on Serum Phosphorus Levels Among Peritoneal Dialysis Patients
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Chertow G, Blumenthal S, Turner S, Roppolo M, Stern L, Chi E
. Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate. Clin J Am Soc Nephrol. 2007; 1(2):305-12.
DOI: 10.2215/CJN.00870805.
View
2.
Chonchol M, Locatelli F, Abboud H, Charytan C, de Francisco A, Jolly S
. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis. 2008; 53(2):197-207.
DOI: 10.1053/j.ajkd.2008.09.021.
View
3.
Koizumi M, Komaba H, Nakanishi S, Fujimori A, Fukagawa M
. Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant. 2011; 27(2):784-90.
DOI: 10.1093/ndt/gfr384.
View
4.
Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T
. An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013). Ther Apher Dial. 2016; 19(6):540-74.
DOI: 10.1111/1744-9987.12378.
View
5.
Wu M, Wu H, Huang X, Ye H, Huang F, Yu X
. Associations between serum mineral metabolism parameters and mortality in patients on peritoneal dialysis. Nephrology (Carlton). 2018; 24(11):1148-1156.
DOI: 10.1111/nep.13535.
View